Kakajiwala Aadil, Bhatti Tricia, Kaplan Bernard S, Ruebner Rebecca L, Copelovitch Lawrence
Division of Nephrology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Division of Pathology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Clin Kidney J. 2016 Feb;9(1):90-6. doi: 10.1093/ckj/sfv119. Epub 2015 Nov 26.
A 7-year-old male with poststreptococcal glomerulonephritis (PSGN) developed hemolytic uremic syndrome (HUS) and achieved remission. He was treated with eculizumab for 1 year. The eculizumab was discontinued and the patient remained in remission. This is the 10th reported case of PSGN associated with HUS. The histopathological feature observed at the 1-year follow-up was indistinguishable from the expected findings in an individual with healed PSGN without associated HUS. The relatively good prognosis in most prior cases and the absence of any reported recurrences strongly suggest that this form of atypical HUS does not warrant long-term eculizumab therapy.
一名患有链球菌感染后肾小球肾炎(PSGN)的7岁男性发展为溶血性尿毒症综合征(HUS)并实现缓解。他接受依库珠单抗治疗1年。依库珠单抗停药后,患者仍处于缓解状态。这是第10例报道的与HUS相关的PSGN病例。1年随访时观察到的组织病理学特征与无相关HUS的已治愈PSGN个体的预期发现没有区别。大多数先前病例相对良好的预后以及没有任何复发报道强烈表明,这种非典型HUS形式无需长期依库珠单抗治疗。